← Leaderboards
Benjamin Y. Xu
University Of Southern California
$2,059,529
Attributed
$2,059,529
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $468.4K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,059,529 · 2
By mechanism
K23$1,143,790 · 1
R01$915,739 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Steven Y Sussman$7,825,274
- David W Simpson$235,442,663
- Adam Matthew Leventhal$15,113,791
- Bijan Najafi$10,971,371
- Florence A Clark$6,367,784
Others in their field
Other Emerging Leaders on “Statistical Models”
- Ted Ross · University Of Georgia$68,763,143
- Leonard Freedman · Leidos Biomedical Research, Inc.$65,587,215
- Yunda Huang · Fred Hutchinson Cancer Center$55,037,960
- Christopher Bee · Suny At Stony Brook$41,239,084
- John Hobbs · Suny At Stony Brook$41,239,084
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$19,087,016
Research focus
Statistical ModelsRisk FactorsPhysiologic Intraocular PressureMeasurementProspectiveResearch Clinical TestingDiagnosisHigh PrevalenceImageImpairmentPrimary Angle Closure GlaucomaBlindnessAqueous HumorReproducibilityAffectCaringGlaucomaGonioscopyAnatomyHigh RiskClinical ApplicationClinical CareAnteriorTraining
Grant awards (7)
Clinical Evaluation and Risk Stratification of Angle Closure Disease Using Quantitative OCT$447,309
R01 · FY2025 · EY · contact PI
Clinical Evaluation and Risk Stratification of Angle Closure Disease Using Quantitative OCT$468,430
R01 · FY2024 · EY · contact PI
Development and Validation of Quantitative Anterior Segment OCT-based Methods to Evaluate Patients with Primary Angle Closure Disease$228,758
K23 · FY2023 · EY · contact PI
Development and Validation of Quantitative Anterior Segment OCT-based Methods to Evaluate Patients with Primary Angle Closure Disease$228,758
K23 · FY2022 · EY · contact PI
Development and Validation of Quantitative Anterior Segment OCT-based Methods to Evaluate Patients with Primary Angle Closure Disease$228,758
K23 · FY2021 · EY · contact PI
Development and Validation of Quantitative Anterior Segment OCT-based Methods to Evaluate Patients with Primary Angle Closure Disease$228,758
K23 · FY2020 · EY · contact PI
Development and Validation of Quantitative Anterior Segment OCT-based Methods to Evaluate Patients with Primary Angle Closure Disease$228,758
K23 · FY2019 · EY · contact PI